Related Experiment Videos
Surgery for Crohn's disease in Ireland
Diseases of the Colon and Rectum
|April 1, 1986
Summary
Approximately 14% of patients underwent curative surgery within ten years of diagnosis. Surgical recurrence rates were comparable to American data, with higher risks in large bowel cases possibly due to conservative surgical methods.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Surgery
Background:
- Surgical intervention is a key treatment modality for various cancers.
- Understanding long-term outcomes, including recurrence, is crucial for patient management.
- Previous studies have established baseline recurrence rates in different regions.
Purpose of the Study:
- To evaluate the rates of curative surgery and surgical recurrence in patients over a ten-year period.
- To compare cumulative surgical recurrence rates with existing data from America.
- To identify factors associated with increased surgical recurrence risk, particularly in large bowel disease.
Main Methods:
- Retrospective analysis of patient data over ten years post-diagnosis.
- Calculation of cumulative incidence for curative surgery.
- Assessment and comparison of cumulative surgical recurrence rates.
- Analysis of disease characteristics, including macroscopic large bowel disease, in relation to recurrence.
Main Results:
- One in seven patients (approximately 14%) had curative surgery within the first decade post-diagnosis.
- Cumulative surgical recurrence rates were found to be similar to those reported in the United States.
- A higher cumulative risk of surgical recurrence was observed in patients with macroscopic disease of the large bowel.
- No operative mortality was recorded in the study cohort.
Conclusions:
- Curative surgery rates and overall recurrence patterns are consistent with international benchmarks.
- The increased risk of recurrence in macroscopic large bowel disease may be linked to conservative surgical strategies.
- The findings support the need for careful consideration of surgical approaches in specific patient groups to optimize outcomes.